Loss of BLK expression as a potential predictor of poor prognosis and immune checkpoint blockade response in NSCLC and contribute to tumor progression

BACKGROUND: Immune checkpoint blockade (ICB) has been proved to have significant anti-tumor effect in the clinical treatment of non-small cell lung cancer (NSCLC). Therefore, biomarkers predicting ICB response can provide better treatment for patients with NSCLC. METHODS: Differential expression gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yingqi, Xu, Jianlin, Qiao, Rong, Zhong, Hua, Xia, Jinjing, Zhong, Runbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127141/
https://www.ncbi.nlm.nih.gov/pubmed/37068401
http://dx.doi.org/10.1016/j.tranon.2023.101671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127141/
https://www.ncbi.nlm.nih.gov/pubmed/37068401
http://dx.doi.org/10.1016/j.tranon.2023.101671

Ejemplares similares